Answers are grounded in this paper and cite their sources.
The novel preservative-free, aqueous low-dose budesonide formulation is highly efficacious even after an initial single treatment. Thus, Budesolv 10 appears to be an effective acute treatment for allergic rhinitis as well as for AR comorbidities like mild asthma and conjunctivitis.
No takes yet. Share an insight, caveat, or question.
Zieglmayer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: